CAMICIOTTOLI, GIANNA
 Distribuzione geografica
Continente #
NA - Nord America 8.679
EU - Europa 6.090
AS - Asia 4.016
SA - Sud America 416
Continente sconosciuto - Info sul continente non disponibili 120
AF - Africa 117
OC - Oceania 97
Totale 19.535
Nazione #
US - Stati Uniti d'America 8.493
RU - Federazione Russa 1.851
IT - Italia 1.687
SG - Singapore 1.098
CN - Cina 909
PL - Polonia 753
HK - Hong Kong 608
IE - Irlanda 504
VN - Vietnam 465
SE - Svezia 420
KR - Corea 348
BR - Brasile 335
FI - Finlandia 209
FR - Francia 178
DE - Germania 172
JO - Giordania 140
CA - Canada 113
IN - India 109
GB - Regno Unito 108
AU - Australia 96
JP - Giappone 90
UA - Ucraina 79
BD - Bangladesh 67
CI - Costa d'Avorio 41
ID - Indonesia 37
TR - Turchia 34
CH - Svizzera 27
AR - Argentina 26
IQ - Iraq 25
MX - Messico 25
NG - Nigeria 21
NL - Olanda 21
BE - Belgio 18
PK - Pakistan 14
EC - Ecuador 13
RO - Romania 13
ZA - Sudafrica 13
JM - Giamaica 12
PH - Filippine 11
CL - Cile 10
CO - Colombia 9
SA - Arabia Saudita 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
ES - Italia 8
UZ - Uzbekistan 8
KE - Kenya 7
MA - Marocco 7
CR - Costa Rica 6
EG - Egitto 6
PY - Paraguay 6
AL - Albania 5
BJ - Benin 5
EU - Europa 5
HN - Honduras 5
PE - Perù 5
PR - Porto Rico 5
RS - Serbia 5
SI - Slovenia 5
TH - Thailandia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
KZ - Kazakistan 4
LT - Lituania 4
MY - Malesia 4
BG - Bulgaria 3
KW - Kuwait 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AT - Austria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
LI - Liechtenstein 2
LV - Lettonia 2
SC - Seychelles 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
Totale 19.409
Città #
Santa Clara 1.885
Warsaw 748
Singapore 746
Ashburn 717
San Jose 527
Dublin 505
Hong Kong 485
Chandler 478
Fairfield 470
Milan 395
Seoul 344
Beijing 221
Woodbridge 200
The Dalles 186
Cambridge 178
Council Bluffs 171
Seattle 164
Wilmington 160
Rome 154
Houston 152
Hefei 149
Buffalo 142
Hanoi 138
Ho Chi Minh City 135
Princeton 133
Jacksonville 132
Florence 126
Lauterbourg 124
Los Angeles 120
Ann Arbor 115
Melbourne 91
Tokyo 87
Moscow 85
Boston 84
New York 81
Medford 78
Boardman 77
Helsinki 71
Lawrence 63
Altamura 57
Mumbai 57
Dallas 51
Munich 50
Kent 47
Phoenix 47
Shanghai 46
Chicago 43
Abidjan 41
Norwalk 36
Redondo Beach 35
San Diego 35
Naples 29
Turin 28
Haiphong 27
São Paulo 27
Falls Church 24
Bern 23
Frankfurt am Main 23
Jakarta 23
Orem 22
Toronto 22
Figino 21
Hillsboro 21
London 21
Bologna 20
Yubileyny 19
Abuja 18
Da Nang 18
Atlanta 17
Brooklyn 17
Brussels 17
Izmir 17
Turku 17
Clifton 16
Bari 15
Chennai 15
Palermo 15
Dong Ket 14
Paris 14
San Francisco 13
Guangzhou 12
Kingston 12
Philadelphia 12
Bengaluru 11
Columbus 11
Genoa 11
Messina 11
Washington 11
Baghdad 10
Catania 10
Vicenza 10
West Jordan 10
Andover 9
Dearborn 9
Miano 9
Montreal 9
Mountain View 9
Padua 9
Reggio Emilia 9
Rio de Janeiro 9
Totale 12.238
Nome #
COPD: maximization of bronchodilation 399
Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD 337
Is intrathoracic tracheal collapsibility correlated to clinical phenotypes and sex in patients with COPD? 329
Immunoglobulin replacement therapy for yellow nail syndrome 314
Interstitial lung disease in systemic sclerosis: Where do we stand? 286
Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease 275
Emphysematous and Nonemphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function. 271
Non-contact detection of breathing using a microwave sensor 257
Discussione di casi clinici: Il caso di Pneumologia 243
Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes. 223
CHANGES IN TRANSCUTANEOUS OXYGEN PARTIAL PRESSURE AS AN INDEX OF RESPONSE TO INHALED METHACHOLINE IN ASTHMATIC PATIENTS. 221
Chronic Obstructive Pulmonary Disease: Pulmonary Function and CT Lung Attenuation Do Not Show Linear Correlation. Paoletti M, Cestelli L, 221
Chronic obstructive pulmonary disease: thin-section CT measurement of airway wall thickness and lung attenuation. 214
Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts. 213
Different respiratory behaviors disclosed by induced bronchoconstriction in mild asthma patients. 204
BODE_index, modified BODE-index and ADO score in Chronic Obstructive Pulmonary Disease: relationship with COPD phenotypes and CT lung density changes 202
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 199
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 199
Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPD. 198
Non-tuberculous mycobacteria: epidemiological pattern in a reference laboratory and risk factors associated with pulmonary disease 195
Glottis Closure Influences Tracheal Size Changes in Inspiratory and Expiratory CT in Patients with COPD. 191
Whole-lung volume and density in spirometrically-gated inspiratory and expiratory CT in systemic sclerosis: correlation with static volumes at pulmonary function tests 186
Induced sputum in systemic sclerosis interstitial lung disease: Comparison to healthy controls and bronchoalveolar lavage 181
ENFISEMA POLMONARE 178
A prospective study on respiratory function in children affected with Systemic Lupus Erithematosus 177
Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: first case report 176
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 174
Pulmonary emphysema and coronary artery calcifications at baseline LDCT and long-term mortality in smokers and former smokers of the ITALUNG screening trial 173
Agreement between two methods fr assessing bioequivalence of inhaled salbutamol. 170
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 170
Studio prospettico della funzione respiratoria in bambini affetti da Lupus Eritematoso Sistemico 170
Comparison of spirometric-gated and -ungated HRCT in COPD. 168
Omalizumab improves asthma-related quality of lifein allergic asthmatic patients 167
Airway response to fenoterol hydrobromide and oxitropium bromide alone or in sequence in stable COPD patients 166
TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life 163
Fog-induced respiratory responses are attenuated by nedocromil sodium in humans 161
Discriminant Profiles of Volatile Compounds in the Alveolar Air of Patients with Squamous Cell Lung Cancer, Lung Adenocarcinoma or Colon Cancer 160
Classification of COPD patients by using a standardised diagnostic questionnaire 159
Thin-section and low-dose volumetric computed tomographic densitometry of the lung in systemic sclerosis. 158
Chest x-ray findings in different Phenotypes, GOLD stages and BODE scores of Chronic Obstructive Pulmonary Disease 158
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients 157
Low agreement of visual rating for detailed quantification of pulmonary emphysema in whole lung CT 156
Asthma remission one, none and one-hundred thousand: the relevance of the patient’s view 155
Chronic effort dyspnea explained by lung function tests and by HRCT and CRX radiografic patterns in COPD: a post-hoc analysis in 51 patients 154
In vitro validation and preliminary clinical application of a software for the computation of lung nodules volume in the Italung-CT trial 154
Characterization of COPD phenotype: comparison of the perceptual response to exercise in emphysema and chronic bronchitis patients. 154
Whole-lung densitometry versus visual assessment of emphysema 153
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 152
Clinical Identification of CT-Determined COPD Phenotypes 150
Clinical Identification of CT-Determined COPD Phenotypes 147
“Adrenaline junkie”: a case report of repeated use of epinephrine 145
Classification of COPD patients by using standardised diagnostic procedures 145
[Lymphangioleiomyomatosis. The computed tomographic aspects in an early case]. 143
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT 143
EFFECT ON LUNG FUNCTION OF METHOTREXATE AND NON-STEROID ANTI-INFLAMMATORY DRUGS IN CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS 141
Classificazione diagnostica standardizzata dei pazienti con BPCO 139
PULMONARY LYMPHANGIOLEIOMYOMATOSIS. A CASE REPORT AND REVIEW 137
Clinical utility of noninvasive methods in the evaluation of scleroderma lung in pediatric age 137
Prediction by pulmonary function tests of HRCT lung density parameters in COPD 136
Effetti della terapia con metotrexate (MTX) e degli antiinfiammatori non steroidei sulla funzione polmonare e sulla capacità di diffusione in bambini affetti da artrite reumatoide giovanile 136
Determination of ai rway resistance (Raw) and pulmonary flow resistance (RL) during methacoline challenge in children 135
Expiratory quantitative HRCT parameters reflect better than inspiratory parameters disfunction in COPD. 134
Cardiovascular comorbidities prevail in the early stages of COPD irrespective of predominant airway or emphysema phenotype 134
Comparison of dose-response slopes obtained by simultaneous assessment of changes in FEV1 and transcutaneous oxygen partial pressure during methacholine challenges in asthmatic patients. 133
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? 132
Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life 132
Modificazioni sequenziali cardio respiratorie in corso di danno lesionale sperimentale da acido oleico 132
Phenotypes of chronic obstructive pulmonary disease 130
Lung densitometry: Why, how and when 129
What does phenotype mean in the field of COPD 128
Omalizumab improves asthma-related quality of life in allergic asthmatic patient 128
High resolution and spirometric synchronization computerized tomography in chronic obstructive bronchopneumopathy 128
PULMONARY FUNCTION IN CHILDREN AFFECTED BY JUVENILE SPONDYLOARTHROPATHY 127
Changes in the pattern of breathing and dyspnea sensation during methacholine-induced bronchoconstriction in asthmatic patiens 127
Valutazione dei parametri quantitativi derivati dalla tomografia computerizzata ad alta risoluzione (HRCT) in pazienti BPCO: confronto con i tests di funzionalità respiratoria 127
Densitometria vs visual score nella valutazione dell’enfisema polmonare con TC 127
Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease 126
Malattie polmonari parenchimali diffuse 126
Severe asthma: One disease and multiple definitions 122
L’edema Polmonare 121
Impiego di un dispositivo di interruzione del flusso delle vie aeree per la misura delle resistenze respiratorie (RL) 121
Identification of a predominant clinical COPD phenotype in clinical practice 121
Spirometrically gated high-resolution CT findings in COPD: lung attenuation vs lung function and dyspnea severity. 121
Valutazione densitometrica polmonare nella sclerosi sistemica. Riproducibilità e correlazioni clinico-funzionali 120
Lung involvement in Juvenile dermatomyositis (JDM): Muscle strenght and pulmonary function tests in children with JDM 116
High resolution computed tomography quantitative parameters in COPD. Comparison with pulmonary function tests 116
Mepolizumab Effectiveness and Allergic Status in Real Life 115
Italian real life experience of Omalizumab 115
Thin section CT and low dose volumetric CT densitometry of the lung in Systemic Sclerosis 111
Studio prospettico sulla funzionalità respiratoria e determinazione della forza muscolare in pazienti di età pediatrica affetti da dermatomiosite 108
Different cell compositions in induced sputum samples from patients with Systemic Sclerosis: relationship with antibodies and interstitial lung fibrosis 107
Defining the contribution of emphysema and chronic bronchitis in COPD patients 104
The Severe Asthma Network in Italy: Findings and Perspectives 104
Spirometric-gated computed tomography quantitative evaluation of lung emphysema in chronic obstructive pulmonary disease: a comparison of 3 techniques. 102
Interessamento polmonare in pazienti asintomatici con artrite reumatoide giovanile (ARG), HLAB27 positivi. Studio prospettico della funzionalità respiratoria 101
Induced sputum in Systemic Sclerosis intrestitial lung disease: comparison to healthy controls and bronchoalveolar lavage 99
Clinical Phenotypes in patients with COPD 99
Diagnostica per immagini della BPCO 99
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 98
Prediction of Pulmonary Function in COPD on the Basis of CT Measurements of Bronchial Wall Thickness 98
Totale 16.093
Categoria #
all - tutte 53.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022596 0 0 0 55 20 12 14 55 22 20 129 269
2022/20232.033 216 235 71 147 179 390 282 104 295 27 57 30
2023/2024811 58 134 170 59 66 84 19 93 8 35 56 29
2024/20255.249 174 520 406 720 1.668 669 65 312 253 94 185 183
2025/20266.051 641 815 490 301 514 209 932 252 417 338 213 929
2026/20271.285 250 187 697 151 0 0 0 0 0 0 0 0
Totale 19.535